Country | Carer administration | Paramedic administration | Hospital administration | Source |
---|---|---|---|---|
Scotland | Buccal midazolam 100% | Rectal diazepam 100% | Buccal midazolam 100% | Delphi panel and patient surveys |
Wales | Buccal midazolam 95% | Rectal diazepam 100% | Buccal midazolam 38% | Delphi panel and patient surveys |
Rectal diazepam 5% | Rectal diazepam 62% | |||
Germany | Rectal diazepam 81% | Rectal diazepam 82% | Rectal diazepam 82% | Delphi panel |
Buccal use of lorazepam tablets 19% | Lorazepam 6% | Lorazepam 6% | ||
Clonazepam 6% | Clonazepam 6% | |||
Phenytoin 6% | Phenytoin 6% | |||
Spain | Rectal diazepam 100% | Rectal diazepam 100% | Rectal diazepam 100% | Delphi panel and patient surveys |
France | Rectal diazepam 92% | Rectal diazepam 84% | Rectal diazepam 84% | Delphi panel |
IV clonazepam 10% | IV clonazepam 10% | |||
Oral clonazepam 8% | ||||
Phenytoin 6% | Phenytoin 6% | |||
Italy | Rectal diazepam 100% | Rectal diazepam 10% | Rectal diazepam 65% | Delphi panel |
IV midazolam 90% | IV midazolam 35% | |||
Switzerland | Rectal diazepam 45% | Rectal diazepam 50% | Rectal diazepam 50% | Clinician interviews |
Buccal lorazepam 54% | IV diazepam 6% | IV diazepam 6% | ||
Intranasal midazolam <2% | IV lorazepam 43% | IV lorazepam 43% | ||
Intranasal midazolam 1% | Intranasal midazolam 1% | |||
IV clonazepam <1% | IV clonazepam <1% | |||
Phenobarbital <1% | Phenobarbital <1% |